U
LIVE

Serial Number

79395398

Owner

Uptake Strategies Limited

Attorney

William C. Wright

Filing Date

Oct 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

U Trademark

Serial Number: 79395398 • Registration: 7602781

U is a trademark filed by Uptake Strategies Limited on October 26, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Uptake Strategies Limited

Index House,

Entity Type: 24

Trademark Details

Filing Date

October 26, 2023

Registration Date

December 17, 2024

Published for Opposition

October 29, 2024

Goods & Services

Providing information, advisory and consultancy services regarding pharmacovigilance, namely preventing, diagnosing and treating adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines or instruments, and regarding medicine, healthcare, pharmacy, biotechnology and regarding medical devices, machines, instruments, equipment and apparatus

Brand design services, namely the design of corporate identities in the nature of the graphic design of logos, typography, icons, color schemes, and key visuals; providing information, advisory and consultancy services relating to brand design, namely to the design of corporate identities in the nature of the graphic design of logos, typography, icons, color schemes, and key visuals; providing information, advisory and consultancy services regarding quality assurance and quality management in the fields of clinical studies, clinical practice and of clinical laboratory practice; providing information, advisory and consultancy services regarding clinical studies, clinical practice and regarding clinical laboratory practice; auditing in the nature of product and service quality evaluation and quality control services for others relating to pharmacovigilance, namely to the prevention, diagnosis and treatment of adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines, instruments, equipment and apparatus, relating to medicine, healthcare, pharmacy, biotechnology and to medical devices, machines, instruments, equipment and apparatus; quality control services for others undertaking their own advertising, marketing, publicity and market analysis and research; quality control services for others undertaking their own brand creation, evaluation, positioning, strategy and testing; quality control services for others undertaking their own design and development of marketing strategies and materials, design and development of publicity strategies and materials and their own design and development of advertising strategies and materials; auditing in the nature of quality evaluation and analysis, quality assurance and quality control for others in the fields of transportation and delivery of pharmaceuticals; auditing in the nature of quality evaluation and analysis, quality assurance and quality control for others undertaking education and training of their workforce and for other providing educational and training services

Providing information, advisory and consultancy services in the fields of transportation and delivery of pharmaceuticals

Providing information, advisory and consultancy services regarding legal affairs, regulatory affairs, legal inspections, legal audits and regarding governmental regulatory inspections and audits in the fields of pharmacovigilance, namely preventing, diagnosing and treating adverse medical reactions experienced after administration of medicine/vaccines, clinical medical care, biotechnology medical treatments or of other treatment by medical devices, machines or instruments, and in the fields of medicine, healthcare, pharmacy, biotechnology and in the field of medical devices, machines, instruments, equipment and apparatus

Advertising services; marketing services; publicity agency services; market analysis and research services; brand creation services in the nature of brand conception, development, evaluation, positioning, strategy and brand testing services in the nature of conducting market studies for consumer reaction to branding; design and development of marketing, publicity and advertising strategies and materials; providing information, advisory and consultancy services regarding advertising, marketing, publicity and regarding market analysis and research; providing information, advisory and consultancy services in the nature of market analysis and research regarding brand creation, evaluation, positioning, strategy and testing in the nature of market research; providing information, advisory and consultancy services relating to the design and development of marketing strategies and materials, development of publicity strategies and materials and relating to the development of advertising strategies and materials

Downloadable textual, audio, visual and audio-visual files in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable podcasts in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable video podcasts in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; downloadable electronic publications in the nature of downloadable books, downloadable magazines and downloadable articles in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus

Arranging, organising and conducting workshops, symposia, talks, lectures, seminars, courses and programmes in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; provision of online non-downloadable textual, audio, visual and audio-visual content and materials in the nature of videos, e-zines and articles in the fields of medicine, healthcare, pharmacy, biotechnology and of medical devices, machines, instruments, equipment and apparatus; providing information, advisory and consultancy services in the fields of education and business training

Providing information, advisory and consultancy services in the field of manufacture of pharmaceuticals

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 24, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 8, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 10, 2025 FICS
FINAL DISPOSITION PROCESSED
Jun 9, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2024 CNEA
EXAMINERS AMENDMENT MAILED
Sep 20, 2024 CNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2024 CNEA
REFUSAL PROCESSED BY IB
Aug 4, 2024 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 16, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 15, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2024 REPR